Dolby Laboratories
DLB
58.35
-0.11
-0.19%
Dolby Laboratories
US · DLB
#2013 by market cap
Listed 1970
58.35
-0.11
-0.19%
Live - 5344 symbols - heartbeat 475s ago
· 2026-10-08 04:26
Pre-market
58.40
+0.09%
After-hours
58.34
-0.02%
- Market cap
- 5.47B
- P/E (TTM)i
- 24.83
- P/Bi
- 2.12
- EPSi
- 2.62
- Div yieldi
- 2.42%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on DLB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.70, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.92% YoY
Margins
- Gross margin
- 88.13%
- Operating margin
- 20.75%
- Net margin
- 18.90%
Key ratios & quality
- PEG ratioi
- 2.16
- Altman Z-Scorei
- 7.70
PEG uses trailing P/E against the 3-year net income growth rate (11.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.24B | 1.16B | 1.28B | 1.25B | 1.30B | 1.27B | 1.35B |
| Gross profit | 927.04M | 1.08B | 1.02B | 1.15B | 1.11B | 1.15B | 1.13B | 1.19B |
| Selling & admin expenses | 507.19M | 549.26M | 555.69M | 556.83M | 634.03M | 612.84M | 604.85M | 647.24M |
| Research & development | 236.79M | 237.87M | 239.05M | 253.64M | 261.17M | 271.52M | 263.66M | 261.79M |
| Operating profit | 183.06M | 293.64M | 220.56M | 340.76M | 217.23M | 262.81M | 264.71M | 279.97M |
| Pretax profit | 196.37M | 282.31M | 239.72M | 354.51M | 215.28M | 250.05M | 312.48M | 303.49M |
| Tax | 154.07M | 26.80M | 8.10M | 36.69M | 31.38M | 48.41M | 48.16M | 46.99M |
| Net profit | 42.31M | 255.51M | 231.62M | 317.82M | 183.90M | 201.64M | 264.32M | 256.49M |
| Basic EPS | 0 | 3 | 2 | 3 | 2 | 2 | 3 | 3 |
| Diluted EPS | 0.39 | 2.44 | 2.25 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 369.56M | 315.55M | 307.02M | 346.71M | 395.63M | 305.00M |
| Gross profit | 333.72M | 271.54M | 267.51M | 303.50M | 350.90M | 264.68M |
| Selling & admin expenses | 160.04M | 158.47M | 164.24M | 161.80M | 172.12M | 160.66M |
| Research & development | 61.71M | 65.98M | 67.47M | 69.08M | 63.65M | 65.75M |
| Operating profit | 111.97M | 47.09M | 35.81M | 72.63M | 115.13M | 38.27M |
| Pretax profit | 120.25M | 55.52M | 41.67M | 71.60M | 119.70M | 43.80M |
| Tax | 28.02M | 8.97M | -7.99M | 17.92M | 24.25M | 14.59M |
| Net profit | 92.23M | 46.54M | 49.65M | 53.68M | 95.45M | 29.21M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 0 |
| Diluted EPS | 0.94 | 0.48 | 0.51 | 0.55 | 0.99 | 0.30 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.50B | 1.38B | 1.55B | 1.76B | 1.31B | 1.49B | 1.19B | 1.39B |
| Cash & ST investments | 1.10B | 916.36M | 1.12B | 1.26B | 809.34M | 884.51M | 482.05M | 702.60M |
| Inventory | 26.21M | 32.33M | 25.55M | 10.97M | 23.55M | 35.62M | 33.73M | 30.42M |
| Total assets | 2.87B | 2.82B | 2.92B | 3.11B | 2.69B | 2.98B | 3.11B | 3.23B |
| Total current liabilities | 285.20M | 306.85M | 267.11M | 315.72M | 277.52M | 422.23M | 417.84M | 437.79M |
| Short-term debt | -- | -- | 15.82M | 15.40M | 13.26M | 13.63M | 12.24M | 10.38M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 494,884,000.00 | 508,719,000.00 | 478,920,000.00 | 501,455,000.00 | 438,528,000.00 | 607,582,000.00 | 623,035,000.00 | 595,814,000.00 |
| Total equity | 2.37B | 2.31B | 2.44B | 2.60B | 2.25B | 2.37B | 2.49B | 2.63B |
| Retained earnings | 2.31B | 2.33B | 2.44B | 2.61B | 2.30B | 2.39B | 2.50B | 2.63B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.39B | 1.34B | 1.39B | 1.41B | 1.41B | 1.33B |
| Cash & ST investments | 626.55M | 699.33M | 702.60M | 644.58M | 594.74M | 670.05M |
| Inventory | 34.59M | 32.42M | 30.42M | 31.26M | 31.93M | 30.77M |
| Total assets | 3.23B | 3.20B | 3.23B | 3.19B | 3.25B | 3.16B |
| Total current liabilities | 457.49M | 388.79M | 437.79M | 443.51M | 474.61M | 416.33M |
| Short-term debt | 10.78M | 10.95M | 10.38M | 10.33M | 9.87M | 9.86M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 646,017,000.00 | 581,750,000.00 | 595,814,000.00 | 589,252,000.00 | 622,362,000.00 | 563,887,000.00 |
| Total equity | 2.58B | 2.61B | 2.63B | 2.60B | 2.63B | 2.59B |
| Retained earnings | 2.60B | 2.62B | 2.63B | 2.60B | 2.63B | 2.60B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 352.20M | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M | 327.25M | 472.20M |
| Depreciation & amortization | 81.28M | 85.12M | 111.88M | 112.76M | 103.61M | 95.51M | 87.33M | 98.60M |
| Free cash flow | 266.85M | 214.14M | 274.86M | 393.30M | 259.12M | 336.74M | 297.25M | 430.26M |
| Dividends paid | -66.16M | -77.50M | -88.58M | -89.17M | -100.07M | -103.41M | -114.58M | -126.60M |
| Stock buybacks / issuance | -66.45M | -306.03M | -114.15M | -155.98M | -509.06M | -132.64M | -158.87M | -118.53M |
| Ending cash balance | 925.25M | 805.59M | 1.08B | 1.23B | 628.37M | 817.97M | 577.75M | 793.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 174.90M | 67.69M | 122.83M | 54.80M | 92.51M | 167.46M |
| Depreciation & amortization | 24.43M | 24.40M | 24.58M | 26.81M | 26.85M | 25.07M |
| Free cash flow | 168.00M | 61.26M | 100.99M | 49.42M | 46.42M | 147.67M |
| Dividends paid | -31.83M | -31.63M | -31.59M | -34.34M | -34.34M | -33.99M |
| Stock buybacks / issuance | -32.54M | -28.64M | -32.07M | -86.95M | -64.99M | -56.50M |
| Ending cash balance | 750.34M | 756.56M | 793.36M | 727.57M | 673.81M | 738.89M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.65 | 11.35 | 9.76 | 12.33 | 7.60 | 8.72 | 10.84 | 10.00 |
| ROA %i | 4.71 | 9.31 | 8.06 | 10.30 | 6.35 | 7.08 | 8.60 | 8.05 |
| ROIC %i | 5.02 | 10.35 | 8.94 | 11.86 | 7.20 | 8.53 | 10.62 | 9.84 |
| 5-year avg ROE %i | 9.00 | 8.60 | 8.49 | 8.99 | 8.50 | 9.87 | 9.85 | 9.90 |
| EBIT margin %i | 26.71 | 22.75 | 20.65 | 27.71 | 17.20 | 20.22 | 20.78 | 20.75 |
| FCF / sales %i | 22.77 | 17.25 | 23.66 | 30.70 | 20.67 | 25.91 | 23.34 | 31.89 |
| Current ratioi | 5.25 | 4.50 | 5.79 | 5.58 | 4.72 | 3.52 | 2.86 | 3.17 |
| Quick ratioi | 5.02 | 4.24 | 5.47 | 5.32 | 4.43 | 3.15 | 2.38 | 2.77 |
| Debt / assetsi | -- | 0.00 | 2.78 | 2.32 | 1.89 | 1.70 | 1.51 | 1.20 |
| LT debt / equityi | -- | -- | 2.68 | 2.18 | 1.68 | 1.57 | 1.40 | 1.09 |
| Interest coveragei | 1,581.14 | 1,661.63 | 1,289.79 | 741.11 | 547.39 | -- | -- | -- |
| Revenue CAGR (3Y) %i | 2.80 | 6.57 | 2.46 | 6.70 | 0.33 | 3.81 | -0.20 | 2.47 |
| Net income CAGR (3Y) %i | -38.72 | 11.14 | 3.87 | 95.14 | -10.31 | -4.64 | -5.50 | 11.48 |
| FCF CAGR (3Y) %i | 32.61 | 15.69 | 0.24 | 13.80 | 6.56 | 7.00 | -8.91 | 18.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.28 | 10.49 | 10.00 | 9.43 | 9.39 | 8.72 |
| ROA %i | 8.18 | 8.57 | 8.05 | 7.57 | 7.52 | 7.12 |
| ROIC %i | 10.09 | 10.31 | 9.84 | 9.27 | 9.23 | 8.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.44 | 21.47 | 20.75 | 19.98 | 19.83 | 19.33 |
| FCF / sales %i | 29.57 | 32.52 | 31.89 | 28.36 | 18.91 | 25.44 |
| Current ratioi | 3.04 | 3.44 | 3.17 | 3.17 | 2.98 | 3.19 |
| Quick ratioi | 2.56 | 3.09 | 2.77 | 2.74 | 2.58 | 2.79 |
| Debt / assetsi | 1.25 | 1.22 | 1.20 | 1.27 | 1.53 | 1.50 |
| LT debt / equityi | 1.15 | 1.08 | 1.09 | 1.17 | 1.52 | 1.46 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:26:38 · For reference only, not investment advice and not tailored to your situation.